Martinez AF, Abe Y, Hong S, Molyneux K, Yarnell D, Löhr H,
Driever W, Acosta MT, Arcos-Burgos M, Muenke M. An Ultraconserved
Brain-Specific Enhancer Within ADGRL3 (LPHN3) Underpins Attention-Deficit/Hyperactivity
Disorder Susceptibility. Biol Psychiatry. 2016 Dec 15;80(12):943-954.
Abstract
BACKGROUND:
Genetic factors predispose individuals to
attention-deficit/hyperactivity disorder (ADHD). Previous studies have reported
linkage and association to ADHD of gene variants within ADGRL3. In this study,
we functionally analyzed noncoding variants in this gene as likely pathological
contributors.
METHODS:
In silico, in vitro, and in vivo approaches were used to
identify and characterize evolutionary conserved elements within the ADGRL3 linkage
region (~207 Kb). Family-based genetic analyses of 838 individuals (372
affected and 466 unaffected patients) identified ADHD-associated single
nucleotide polymorphisms harbored in some of these conserved elements.
Luciferase assays and zebrafish green fluorescent protein transgenesis tested
conserved elements for transcriptional enhancer activity. Electromobility shift
assays were used to verify transcription factor-binding disruption by ADHD risk
alleles.
RESULTS:
An ultraconserved element was discovered (evolutionary
conserved region 47) that functions as a transcriptional enhancer. A
three-variant ADHD risk haplotype in evolutionary conserved region 47, formed
by rs17226398, rs56038622, and rs2271338, reduced enhancer activity by 40% in
neuroblastoma and astrocytoma cells (pBonferroni < .0001). This enhancer
also drove green fluorescent protein expression in the zebrafish brain in a
tissue-specific manner, sharing aspects of endogenous ADGRL3 expression. The
rs2271338 risk allele disrupts binding of YY1 transcription factor, an
important factor in the development and function of the central nervous system.
Expression quantitative trait loci analysis of postmortem human brain tissues
revealed an association between rs2271338 and reduced ADGRL3 expression in the
thalamus.
CONCLUSIONS:
These results uncover the first functional evidence of
common noncoding variants with potential implications for the pathology of
ADHD.
Courtesy of: http://www.medscape.com/viewarticle/876123
No comments:
Post a Comment